COMMON STOCK (Details Narrative) - USD ($) |
1 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 27, 2025 |
Feb. 29, 2024 |
Jan. 31, 2024 |
Dec. 31, 2023 |
Nov. 30, 2023 |
Jul. 31, 2021 |
Aug. 31, 2025 |
Feb. 28, 2025 |
|
| Defined Benefit Plan Disclosure [Line Items] | ||||||||
| Common stock, shares authorized | 75,000,000 | 75,000,000 | ||||||
| Common stock, par value | $ 0.001 | $ 0.001 | ||||||
| Number of issued shares of common stock | 930,000 | 185,000 | 555,000 | 25,000 | ||||
| Total proceeds | $ 18,600 | $ 3,700 | $ 11,100 | $ 500 | ||||
| Share price | $ 0.02 | $ 0.02 | $ 0.02 | $ 0.02 | ||||
| Common stock, shares outstanding | 3,695,000 | 3,695,000 | 6,695,000 | |||||
| Common stock, shares issued | 3,695,000 | 6,695,000 | ||||||
| Rassul Sadukbayev [Member] | ||||||||
| Defined Benefit Plan Disclosure [Line Items] | ||||||||
| Number of issued shares of common stock | 5,000,000 | |||||||
| Share price | $ 0.001 | |||||||
| Total proceeds | $ 5,000 | |||||||
| Rassul Sadukbayev [Member] | Restricted Stock [Member] | ||||||||
| Defined Benefit Plan Disclosure [Line Items] | ||||||||
| Restricted shares | 5,000,000 | 2,000,000 | ||||||
| Outstanding share capital | 74.68% | 54.13% | ||||||
| Cancelled shares | 3,000,000 | |||||||
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|